![Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity - ScienceDirect Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1535610821003391-fx1.jpg)
Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity - ScienceDirect
![Treatment of subcutaneous TB32047-allografts with the SGS6 therapy.... | Download High-Quality Scientific Diagram Treatment of subcutaneous TB32047-allografts with the SGS6 therapy.... | Download High-Quality Scientific Diagram](https://www.researchgate.net/profile/Kristin-Pape/publication/288830360/figure/fig5/AS:314875315277827@1452083533406/Treatment-of-subcutaneous-TB32047-allografts-with-the-SGS6-therapy-Subcutaneous.png)
Treatment of subcutaneous TB32047-allografts with the SGS6 therapy.... | Download High-Quality Scientific Diagram
Novel Pancreatic Cancer Cell Lines Derived from Genetically Engineered Mouse Models of Spontaneous Pancreatic Adenocarcinoma: Applications in Diagnosis and Therapy | PLOS ONE
![Cancers | Free Full-Text | CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer | HTML Cancers | Free Full-Text | CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer | HTML](https://www.mdpi.com/cancers/cancers-14-00326/article_deploy/html/images/cancers-14-00326-g002-550.jpg)
Cancers | Free Full-Text | CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer | HTML
CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer
![Cancers | Free Full-Text | Genome-Wide CRISPR Screening Identifies DCK and CCNL1 as Genes That Contribute to Gemcitabine Resistance in Pancreatic Cancer | HTML Cancers | Free Full-Text | Genome-Wide CRISPR Screening Identifies DCK and CCNL1 as Genes That Contribute to Gemcitabine Resistance in Pancreatic Cancer | HTML](https://www.mdpi.com/cancers/cancers-14-03152/article_deploy/html/images/cancers-14-03152-g002-550.jpg)
Cancers | Free Full-Text | Genome-Wide CRISPR Screening Identifies DCK and CCNL1 as Genes That Contribute to Gemcitabine Resistance in Pancreatic Cancer | HTML
![IJMS | Free Full-Text | The Effect of GPRC5a on the Proliferation, Migration Ability, Chemotherapy Resistance, and Phosphorylation of GSK-3β in Pancreatic Cancer | HTML IJMS | Free Full-Text | The Effect of GPRC5a on the Proliferation, Migration Ability, Chemotherapy Resistance, and Phosphorylation of GSK-3β in Pancreatic Cancer | HTML](https://www.mdpi.com/ijms/ijms-19-01870/article_deploy/html/images/ijms-19-01870-g002.png)
IJMS | Free Full-Text | The Effect of GPRC5a on the Proliferation, Migration Ability, Chemotherapy Resistance, and Phosphorylation of GSK-3β in Pancreatic Cancer | HTML
![CDK7 inhibition augments response to multidrug chemotherapy in pancreatic cancer | Journal of Experimental & Clinical Cancer Research | Full Text CDK7 inhibition augments response to multidrug chemotherapy in pancreatic cancer | Journal of Experimental & Clinical Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13046-022-02443-w/MediaObjects/13046_2022_2443_Fig1_HTML.png)
CDK7 inhibition augments response to multidrug chemotherapy in pancreatic cancer | Journal of Experimental & Clinical Cancer Research | Full Text
CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer
![CDK7 inhibition augments response to multidrug chemotherapy in pancreatic cancer | Journal of Experimental & Clinical Cancer Research | Full Text CDK7 inhibition augments response to multidrug chemotherapy in pancreatic cancer | Journal of Experimental & Clinical Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13046-022-02443-w/MediaObjects/13046_2022_2443_Fig3_HTML.png)
CDK7 inhibition augments response to multidrug chemotherapy in pancreatic cancer | Journal of Experimental & Clinical Cancer Research | Full Text
![Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity - ScienceDirect Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1535610821003391-gr5.jpg)
Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity - ScienceDirect
![Chemotherapy-induced COX-2 upregulation by cancer cells defines their inflammatory properties and limits the efficacy of chemoimmunotherapy combinations | Nature Communications Chemotherapy-induced COX-2 upregulation by cancer cells defines their inflammatory properties and limits the efficacy of chemoimmunotherapy combinations | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-022-29606-9/MediaObjects/41467_2022_29606_Fig7_HTML.png)
Chemotherapy-induced COX-2 upregulation by cancer cells defines their inflammatory properties and limits the efficacy of chemoimmunotherapy combinations | Nature Communications
Genome-Wide CRISPR Screening Identifies DCK and CCNL1 as Genes That Contribute to Gemcitabine Resistance in Pancreatic Cancer
![Establishment of a novel human cell line retaining the characteristics of the original pancreatic adenocarcinoma, and evaluation of MEK as a therapeutic target Establishment of a novel human cell line retaining the characteristics of the original pancreatic adenocarcinoma, and evaluation of MEK as a therapeutic target](https://www.spandidos-publications.com/article_images/ijo/56/3/IJO-56-03-0761-g01.jpg)
Establishment of a novel human cell line retaining the characteristics of the original pancreatic adenocarcinoma, and evaluation of MEK as a therapeutic target
![Chemotherapy-induced COX-2 upregulation by cancer cells defines their inflammatory properties and limits the efficacy of chemoimmunotherapy combinations. - Abstract - Europe PMC Chemotherapy-induced COX-2 upregulation by cancer cells defines their inflammatory properties and limits the efficacy of chemoimmunotherapy combinations. - Abstract - Europe PMC](https://europepmc.org/articles/PMC9018752/bin/41467_2022_29606_Fig6_HTML.jpg)